Limitations of human occipital scalp hair follicle organ culture for studying the effects of minoxidil as a hair growth enhancer

Experimental Dermatology

Volumn 13, Issue 10, 2004, Pages 635-642

  Magerl, Markus ^a,b   Paus, Ralf ^c   Farjo, Nilofer ^d   Müller Röver, Sven ^c,e   Peters, Eva M J ^c   Foitzik, Kerstin ^c   Tobin, Desmond J ^a  

^a UNIVERSITY OF BRADFORD   (United Kingdom)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d Farjo Medical Centre   (United Kingdom)

^e HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Alopecia; Anagen; Catagen; Hair growth cycle; Insulin

Indexed keywords

MINOXIDIL; SULFATE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HAIR FOLLICLE; HAIR GROWTH; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; IN VITRO STUDY; MALE; MALE TYPE ALOPECIA; MICRODISSECTION; REPRODUCIBILITY; SCALP HAIR; TISSUE CULTURE;

ADULT; AGED; DERMATOLOGIC AGENTS; FEMALE; HAIR FOLLICLE; HUMANS; INSULIN; MALE; MIDDLE AGED; MINOXIDIL; ORGAN CULTURE TECHNIQUES;

EID: 5144231072     PISSN: 09066705     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0906-6705.2004.00207.x     Document Type: Article

References (43)

1. Stenn K S, Paus R. Controls of hair follicle cycling. Physiol Rev 2001: 81: 449-494.
2. Price V H. Treatment of hair loss. N Engl J Med 1999: 341:964-973.
3. Price V H, Menefee E, Sanchez M, Ruane P, Kaufman K D. Changes in hair weight and hair count in men with androgenetic alopecia after treatment with finasteride, 1 mg, daily. J Am Acad Dermatol 2002: 46: 517-523.
4. Olsen E A, Dunlap F E, Funicella T et al. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol 2002:47:377-385.
5. Uno H, Cappas A, Brigham P. Action of topical minoxidil in the bald stump-tailed macaque. J Am Acad Dermatol 1987: 16: 657-668.
6. Li Z, Nater C, Kinsella J, Chrest F, Lakatta E G. Minoxidil inhibits proliferation and migration of cultured vascular smooth muscle cells and neointimal formation after balloon catheter injury. J Cardiovasc Pharmacol 2000: 36: 270-276.
7. + channel-dependent fashion. J Invest Dermatol 1996: 107: 229-234.
8. Nakaya Y, Hamaoka H, Kato S, Arase S. Effect of minoxidil sulfate and pinacidil on single potassium channel current in cultured human outer root sheath cells and dermal papilla cells. J Dermatol Sci 1994: 7: S104-S108.
9. Buhl A E, Waldon D J, Conrad S J et al. Potassium channel conductance: a mechanism affecting hair growth both in vitro and in vivo. J Invest Dermatol 1992: 98: 315-319.
10. Buhl A E, Conrad S J, Waldon D J, Brunden M N. Potassium channel conductance as a control mechanism in hair follicles. J Invest Dermatol 1993: 101: 148S-152S.
11. Burton J L, Schutt W H, Caldwell I W. Hypertrichosis due to diazoxide. Br J Dermatol 1975: 93: 707-711.
12. Goldberg M R. Clinical pharmacology of pinacidil, a prototype for drugs that affect potassium channels. J Cardiovasc Pharmacol 1988: 12 (Suppl. 2): S41-S47.
13. Lachgar S, Charveron M, Gall Y, Bonafe J L. Minoxidil upregulates the expression of vascular endothelial growth factor in human hair dermal papilla cells. Br J Dermatol 1998: 138: 407-411.
14. Wester R C, Maibach H I, Guy R H, Novak E. Minoxidil stimulates cutaneous blood flow in human balding scalps: pharmacodynamics measured by laser Doppler velocimetry and photopulse plethysmography. J Invest Dermatol 1984: 82: 515-517.
15. Murad S, Pinnell S R. Suppression of fibroblast proliferation and lysyl hydroxylase activity by minoxidil. J Biol Chem 1987: 262: 11973-11978.
16. Michelet J F, Commo S, Billoni N, Mahe Y F, Bernard B A, Activation of cytoprotective prostaglandin systhase-1 by minoxidil as a possible explanation for its hair growth-stimulating effect. J Invest Dermatol 1997: 108: 205-209.
17. Buhl A E, Waldon D J, Baker C A, Johnson G A. Minoxidil sulfate is the active metabolite that stimulates hair follicles. J Invest Dermatol 1990: 95: 553-557.
18. Dooley T P, Walker C J, Hirshey S J et al. Localization of minoxidil sulfotransferase in rat liver and the outer root sheath of anagen pelage and vibrissa follicles. J Invest Dermatol 1991: 96: 65-70.
19. Kudlacek P E, Clemens D L, Halgard C M, Anderson R J. Characterization of recombinant human liver dehydro-epiandrosterone sulfotransferase with minoxidil as the substrate. Biochem Pharmacol 1997: 53: 215-221.
20. Schwanstecher M, Sieverding C, Dorschner H et al. Potassium channel openers require ATP to bind to and act through sulfonylurea receptors. EMBO J 1998: 17: 5529-5535.
21. Paus R. Control of the hair cycle and hair disease as cycling disorders. Curr Opin Dermatol 1996: 2: 248-258.
22. Trüeb R M. Molecular mechanisms of androgenetic alopecia. Exp Gerontol 2002: 37: 981-990.
23. Van Steensel M A, van Geel M, Steiljen P M. The molecular basis of hair growth. Eur J Dermatol 2001: 11:348-352.
24. Cotsarelis G, Millar S E. Towards a molecular understanding of hair loss and its treatment. Trends Mol Med 2001: 7: 293-301.
25. Civatte J, Laux B, Simpson N B, Vickers C F. 2% topical minoxidil solution in male-pattern baldness: preliminary European results. Dermatologica 1987: 175 (Suppl. 2): 42-49.
26. Fiedler-Weiss V C, Buys C M. Response to minoxidil in severe alopecia areata correlates with T lymphocyte stimulation. Br J Dermatol 1987: 117: 759-763.
27. Kubilus J, Kvedar J C, Baden H P. Effect of minoxidil on pre- and postconfluent keratinocytes. J Am Acad Dermatol 1987: 6: 648-652.
28. Tanigaki-Obana N, Ito M. Effects of cepharanthine and minoxidil on proliferation, differentiation and keratinization of cultured cells from the murine hair apparatus. Arch Dermatol Res 1992: 284: 290-296.
29. O'Keefe E, Payne R E Jr. Minoxidil: inhibition of proliferation of keratinocytes in vitro. J Invest Dermatol 1991:97:534-536.
30. Kurata S, Uno H, Allen-Hoffmann B L. Effects of hypertrichotic agents on follicular and nonfollicular cells in vitro. Skin Pharmacol 1996: 9: 3-8.
31. Boyera N, Galey I, Bernard B A. Biphasic effects of minoxidil on the proliferation and differentiation of normal human keratinocytes. Skin Pharmacol 1997: 10:206-220.
32. Philpott M P, Green M R, Kealey T. Human hair growth in vitro. J Cell Sci 1990: 97: 463-471.
33. Philpott M P, Sanders D A, Kealey T. Effects of insulin and insulin-like growth factors on cultured human hair follicles: IGF-I at physiologic concentrations is an important regulator of hair follicle growth in vitro. J Invest Dermatol 1994: 102: 857-861.
34. Buhl A E, Waldon D J, Kawabe T T, Holland J M. Minoxidil stimulates mouse vibrissae follicles in organ culture. J Invest Dermatol 1989: 92: 315-320.
35. Kamiya T, Shirai A, Kawashima S et al. Hair follicle elongation in organ culture of skin from newborn and adult mice. J Dermatol Sci 1998: 7: 54-60.
36. Imai R, Jindo T, Miura Y et al. Organ culture of human hair follicles in serum-free medium. Arch Dermatol Res 1993: 284: 466-471.
37. Tobin D J, Mandir N, Dover R. Morphological analysis of in vitro human hair growth. Arch Dermatol Res 1993: 285:158-164.
38. Magerl M, Kauser S, Paus R, Tobin D J. Simple and rapid method to isolate and culture follicular papillae from human scalp hair follicles. Exp Dermatol 2002: 11: 381-385.
39. Hopp L, Bunker C H. Lipophilic impurity of phenol red is a potent cation transport modulator. J Cell Physiol 1993: 157: 594-602.
40. Lubin M. An impurity in phenol red opens an ion channel in cultured human cells. In Vitro Cell Dev Biol Anim 1993: 29A: 597-600.
41. Wang H Z, Chang C H, Lin C P, Tsai M C. Using MTT viability assay to test the cytotoxicity of antibiotics and steroid to cultured porcine corneal endothelial cells. J Ocul Pharmacol Ther 1996: 2: 35-43.
42. Soma T, Tsuji Y, Hibino T. Involvement of transforming growth factor-beta2 in catagen induction during the human hair cycle. J Invest Dermatol 2002: 118: 993-997.
43. Westgate G E, Gibson W T, Kealey T, Philpott M P. Prolonged maintenance of human hair follicles in vitro in a serum-free medium. Br J Dermatol 1993: 129: 372-379.